Search

Ayr Wellness sold its cannabis cultivation facility in Ohio for $28.5 million to a New York-based real estate investment trust, but the company will continue to operate the facility. < Back Cannabis MSO Ayr cannabis cultivation facility in Ohio sells for $28.5 million Feb 4, 2026 Margaret Jackson MJbizDaily Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Ayr Wellness will continue to operate the facility, which was acquired by a New York-based real estate investment trust. Cannabis MSO Ayr cannabis cultivation facility in Ohio sells for $28.5 million is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

Congresswoman Emily Randall is urging the federal government to consider relaxing strict drug testing rules for transportation workers concerning marijuana use outside of work hours to ensure a robust workforce, especially for ferries in Washington. However, the U.S. Department of Transportation (DOT) has advised that federal drug testing requirements remain in effect until the cannabis rescheduling process is complete, and former Transportation Secretary Pete Buttigieg suggested that rescheduling marijuana to Schedule III would likely not alter the DOT's testing requirements. Recent scientific reviews also indicate that there is little research supporting the idea that THC concentration in the blood correlates to driving impairment. < Back Feds Should Consider ‘Relaxing’ Marijuana Drug Testing Rules For Transportation Workers, Congresswoman Says Jan 26, 2026 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A Democratic congresswoman is pushing the federal government to consider “relaxing” strict drug testing rules for transportation workers that punish people for marijuana use outside of work hours that doesn’t actually lead to being high on the job. Rep. Emily Randall (D-WA) told colleagues at a hearing this month that current policy is impeding efforts to ensure there’s a “robust workforce” to staff ferries that are a popular form of transportation in her home state of Washington. The congresswoman, who is a co-chair of the Congressional Ferry Caucus, said lawmakers need to be open to “creative solutions” to the problem. “Federal regulations require drug testing for some maritime employees in safety-sensitive positions, including ferry workers,” she said. We could consider relaxing the rules around recreational marijuana use in states where it’s legal, as long as it’s not used on the job and outside a certain window before their shift.” “Right now, you could drug test positive for a month or longer after using legal recreational marijuana in Washington and be unable to work as a ferry operator,” Randall said at the the “member day” hearing before the House Transportation and Infrastructure Committee. Randall is cosponsoring legislation to federally legalize marijuana, promote equity and address the collateral consequences of prohibition. The Marijuana Opportunity, Reinvestment and Expungement (MORE) Act passed the House twice under Democratic control but has not advanced in the current Congress. While that bill would deschedule marijuana by removing it from the Controlled Substances Act (CSA) altogether, the Trump administration is actively considering a proposal to move cannabis from Schedule I of the CSA to Schedule III. Last month, the U.S. Department of Transportation (DOT) published a bulletin advising that all safety-sensitive workers must still comply with federal drug testing requirements, even as the president is directing the attorney general to complete a cannabis rescheduling process. While the department didn’t quite specify what would change if the reform is ultimately enacted, it in effect said that nothing has changed for now. DOT clarified that, until Attorney General Pam Bondi finalizes the rescheduling action, marijuana remains a Schedule I drug. Therefore, it “remains unacceptable for any safety‐sensitive employee subject to drug testing under the Department of Transportation’s drug testing regulations to use marijuana.” Additionally, “Until the rescheduling process is complete, the Department of Transportation’s drug testing process and regulations will not change,” the notice says. “Transportation employees in safety-sensitive positions will still be subject to testing for marijuana,” DOT said. “Furthermore, the Department’s guidance on medical and recreational marijuana and CBD are still in effect.” Laboratories, medical review officers and substance misuse professionals must still comply with existing drug testing rules, so there are “no changes to your roles and responsibilities as they relate to marijuana.” “We will continue to monitor the rescheduling process and update the transportation industry as appropriate,” the department said. “We want to assure the traveling public that our transportation system is the safest it can possibly be.” While it seemed as if DOT was leaving room open for a possible internal policy change if marijuana rescheduling is ultimately finalized, former Transportation Secretary Pete Buttigieig said in 2024 that placing cannabis in Schedule III wouldn’t affect drug testing policies for commercial truckers, noting that the department specifically lists marijuana as substance to screen. “Our understanding of the rescheduling of marijuana from Schedule I to schedule III is that it would not alter DOT’s marijuana testing requirements with respect to the regulated community,” the former Biden administration official said. “For private individuals who are performing safety-sensitive functions subject to drug testing, marijuana is identified by name, not by reference to one of those classes. So even if it moves in its classification, we do not believe that that would have a direct impact on that authority.” The reason rescheduling on its own wouldn’t change DOT policy is based on an interpretation of the 1991 Omnibus Transportation Employee Testing Act, which grants the transportation secretary with discretion to test for any controlled substances that they’ve “determined has a risk to transportation safety.” Buttigieg was responding to a question from Rep. Rick Crawford (R-AR) during a House Transportation and Infrastructure Committee hearing. The congressman had referenced concerns from the American Trucking Associations (ATA) “about the broad public health and safety consequences of reclassification on the national highway system and its users.” The latest notice comes about three months after DOT proposed a separate rule to update its drug testing guidelines, revising terminology around cannabis in a way that provides more specificity related to THC. While it’s widely understood that driving under the influence of cannabis is dangerous, the relationship between consumption and impairment is a messy one. In 2024, for example, a scientific review of available evidence on the relationship between cannabis and driving found that most research “reported no significant linear correlations between blood THC and measures of driving,” although there was an observed relationship between levels of the cannabinoid and reduced performance in some more complex driving situations. “The consensus is that there is no linear relationship of blood THC to driving,” the paper concluded. “This is surprising given that blood THC is used to detect cannabis-impaired driving.” In a separate 2024 report, NHTSA said there’s “relatively little research” backing the idea that THC concentration in the blood can be used to determine impairment, again calling into question laws in several states that set “per se” limits for cannabinoid metabolites. “Several states have determined legal per se definitions of cannabis impairment, but relatively little research supports their relationship to crash risk,” that report says. “Unlike the research consensus that establishes a clear correlation between [blood alcohol content] and crash risk, drug concentration in blood does not correlate to driving impairment.” Similarly, a Department of Justice (DOJ) researcher said last February that states may need to “get away from that idea” that marijuana impairment can be tested based on the concentration of THC in a person’s system. “If you have chronic users versus infrequent users, they have very different concentrations correlated to different effects,” Frances Scott, a physical scientist at the National Institute of Justice (NIJ) Office of Investigative and Forensic Sciences under DOJ, said. The post Feds Should Consider ‘Relaxing’ Marijuana Drug Testing Rules For Transportation Workers, Congresswoman Says appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

A newly disclosed DOJ memo reveals the federal law denying gun rights to cannabis users faces "potential litigation risk," while a CRS report suggests the new federal ban on hemp THC products may be difficult to broadly enforce. In state news, Kentucky's governor announced medical cannabis sales are "very close" to launching, and the Ohio Senate is scheduled to vote on a bill that would recriminalize possession of cannabis purchased out of state and remove consumer anti-discrimination protections. < Back Can the feds actually enforce the new hemp THC product ban? (Newsletter: December 8, 2025) Dec 8, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *DOJ memo on guns & marijuana users; Senator blocks Trump’s drug czar pick; KY gov: Medical cannabis sales “very close”; OH marijuana recriminalization* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *Hold on, just one second before you read today’s news. *Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* A newly disclosed Department of Justice guidance memo obtained by Marijuana Moment shows that officials knew the federal law denying gun rights to cannabis consumers is vulnerable to “potential litigation risk”—a revelation that comes as the Supreme Court is taking up a case on the issue. The Congressional Research Service published a report on a newly approved federal ban on hemp THC products—saying it “remains unclear if and how” the prohibition will be applied and that Drug Enforcement Administration and Food and Drug Administration officials “may lack the resources to broadly enforce” it. Sen. Michael Bennet (D-CO) blocked Republican leaders’ move to confirm Sara Carter Bailey as director of the White House Office of National Drug Control Policy on an expedited basis as part of a group of other nominees from President Donald Trump. Kentucky Gov. Andy Beshear (D) said the first medical cannabis products should be on dispensary shelves “within the next couple of weeks” and that the launch of sales is “very, very close”—pointing out that marijuana is an alternative for “people that might have otherwise been taking opioids.” The Ohio Senate is expected to vote this week on a bill to scale back the voter-approved marijuana legalization law by recriminalizing possession of cannabis purchased in another state and removing anti-discrimination protections for consumers in parental rights, organ transplants and professional licensing. The World Health Organization’s Expert Committee on Drug Dependence rejected a proposal to ease a global ban on coca leaf—even as a review showed the plant does not have any “clinically meaningful public health harms” but that its prohibition creates “substantial public health harms.” */ FEDERAL* A former Drug Enforcement Administration agent was indicted on federal charges of conspiring to traffic drugs and launder millions of dollars for a Mexican cartel. Sen. Kirsten Gillibrand (D-NY) will speak at a cannabis event on January 29. Rep. Ilhan Omar (D-MN) tweeted, “The cannabis industry is thriving but the communities harmed most by the War on Drugs are being left out. Today, I joined @RepTroyCarter, @RepLSimon, and @repdinatitus to introduce the RESPECT Resolution to ensure that the economic benefits are shared by those who were harmed by failed policies.” */ STATES* Commonwealth of the Northern Mariana Islands Gov. David Apatang (I) issued an executive order transferring marijuana regulation authority from the Commonwealth Cannabis Commission to the Alcohol Beverage and Tobacco Control Division. North Carolina Gov. Josh Stein (D) touted a grant to a hemp company. Wisconsin’s Assembly minority leader discussed public support for marijuana reform. California regulators announced recalls of marijuana products due to the presence of aspergillus and due to lack of good manufacturing practices. Separately, the Cannabis Authority Board of Directors will meet on Monday. Colorado regulators published health and safety advisories about marijuana products that exceed acceptable limits of total yeast, mold and elemental impurities. Illinois regulators filed proposed changes to medical cannabis rules. Arkansas regulators delayed action on a proposed rule to limit out-of-state companies from controlling medical cannabis businesses. Washington State regulators denied a petition to revise marijuana social equity rules. Tennessee regulators published a notice about the transition of hemp product regulation to a new agency. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ LOCAL* Kansas City, Missouri’s mayor is proposing to ban the sale of intoxicating cannabinoids, synthetic cannabinoids, nitrous oxide, bath salts, K2 and kratom. */ INTERNATIONAL* Canadian officials published updated data on medical cannabis use. */ SCIENCE & HEALTH* A study’s results “support the role of cannabis terpenes as partial agonists at CB1R and CB2R and provide the basis for selecting terpenes or terpene mixture for affecting physiological functions involving these receptors.” A study provided “initial evidence that [psilocybin-assisted therapy] can be feasibly and safely integrated into hospice care for terminally ill patients.” */ ADVOCACY, OPINION & ANALYSIS* The Dallas Morning News editorial board said a new scientific review suggests Texas lawmakers should be cautious about further expanding medical cannabis access. */ BUSINESS* Heirloom Remedies is being ordered by a judge to pay the federal government $312,651 in damages and penalties for allegedly making misrepresentations to secure COVID-related loans. */ CULTURE* Jeff Bridges said his favorite odor, before he lost his sense of smell from COVID, was “some fresh weed.” *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: *Photo courtesy of Chris Wallis // Side Pocket Images.* The post Can the feds actually enforce the new hemp THC product ban? (Newsletter: December 8, 2025) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

Blunt DC WEBSITE MENU REVIEWS 1606 K Street Northwest, Washington, DC, USA About OVERALL 4.0 average rating is 4 out of 5 EXPERIENCE 4.1 average rating is 4.1 out of 5 QUALITY 4.0 average rating is 4 out of 5 SERVICE 3.9 average rating is 3.9 out of 5 SELECTION 4.1 average rating is 4.1 out of 5 PRICES 3.7 average rating is 3.7 out of 5 Blunt DC on K Street NW offers a no-nonsense approach to cannabis shopping. The dispensary focuses on providing essential flower, pre-rolls, and concentrates for busy urbanites. Its central location makes it a convenient stop for downtown professionals. The staff keeps interactions efficient while ensuring quality recommendations. Ideal for those seeking a quick, reliable cannabis source. Recent Reviews Check back soon Once posts are published, you’ll see them here. Trending Nearby Triple Burger by Alt Sol - Green Theory Recently harvested by DC craft cultivator Alt Sol, this phenomenal Triple Burger just dropped at Washington DC medical marijuana dispensa... Snoop Dogg OG by SunMed - Columbia Care Dispensary (Chevy Chase, Maryland) This batch of Snoop Dogg OG, named after the rap legend and cannabis enthusiast Snoop Dogg himself, is the "shizzle". Currently available... Cookies & Alt Sol "Madrina" Strain Review - Takoma Wellness Center Madrina, cultivated by Alt Sol and available at Takoma Wellness Center in Washington, DC, comes with a reputation as bold as its name. In... 1 2 3 4 5 best weed in DC (1,159) 1,159 posts DC flower (1,084) 1,084 posts DC I-71 (1,029) 1,029 posts terps (997) 997 posts DC Storefront (670) 670 posts heavy trichomes (662) 662 posts Indica Heavy Hybrid (613) 613 posts DC weed delivery (534) 534 posts starry trichomes (509) 509 posts Indica (477) 477 posts 50/50 Hybrid (421) 421 posts Sativa Dominant Hybrid (252) 252 posts Sativa (211) 211 posts Gelato (154) 154 posts DC Medical Marijuana (146) 146 posts Medical Marijuana (138) 138 posts Maryland Medical Marijuana (113) 113 posts Maryland Flower (105) 105 posts Runtz (101) 101 posts Elevated Lounge (95) 95 posts GSC (91) 91 posts alternative solutions (84) 84 posts Takoma Wellness Center (80) 80 posts The Gift Givers (78) 78 posts Maryland Recreational (76) 76 posts concentrate (74) 74 posts best weed in Maryland (74) 74 posts Zkittles (69) 69 posts edibles (69) 69 posts Alt Sol (59) 59 posts

In the cannabis industry, employer branding is crucial for attracting and retaining top talent. The pandemic has shifted the focus from physical office perks to authentic culture, relationships, and communication. A strong employer brand impacts recruitment, retention, and productivity, leading to long-term growth. Leadership behavior sets the tone, and transparency in messaging and visual identity is key. Top talent seeks dynamic challenges, internal mobility, and real benefits like healthcare and paid leave. Creating genuine human moments, even simple ones, builds trust and a supportive workplace. Employer branding is a survival strategy in the cannabis industry, as employees want to believe in where they work. < Back Employer Branding: Building Culture as Your Competitive Edge Sep 11, 2025 Will Read MG Magazine Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link In the cannabis industry, where startup energy meets regulatory complexity and rapid growth, competition for skilled, mission-driven talent is fierce. For founders and operators, this creates a crucial question: What makes someone want to work for your company? An even more pertinent question is “How much are you investing in branding your workplace?” The pandemic permanently shifted how people experience work. With remote and hybrid environments becoming the norm, employer branding is no longer about cool office spaces or stocked fridges. In fact, building a company people want to work for today often means crafting experiences that have little to do with a physical location. It’s no longer about the place; it’s about the people. Culture is defined not by amenities, but by the relationships, communication, and energy your team brings to each other every day. If your team feels comfortable being themselves, sharing ideas, and connecting authentically (yes, even across Zoom calls or Slack channels), you’re already building a strong employer brand. Authenticity is key. It can’t be manufactured, and it definitely can’t be faked. The more real your company culture feels, the more attractive it becomes to potential hires. [image: Group of WeedMaps employees in the cannabis industry posing together outdoors in front of branded company signage.] Photo: WeedMaps Some may dismiss culture-building as soft or secondary to business operations. But your employer brand directly impacts recruitment, retention, and productivity. When people enjoy where they work and feel valued, they stay longer, collaborate better, and often become advocates for the company. And let’s be real: Hiring is expensive. Onboarding takes time. Training takes energy. When someone leaves, you lose more than just a role; you also lose momentum. That’s why a strong employer brand is a strategic asset. When employees feel aligned with your values and leadership, the ripple effects are real: better work, stronger client relationships, and long-term, sustainable growth. If you’re in a leadership position, your behavior sets the tone. When you lead with empathy and authenticity, your team feels it. And when your employees are energized and engaged, they pass that energy on to clients, partners, and each other. Culture isn’t about being performative. It’s about consistently showing up. Messaging that reflects who you really are as a company (i.e. human, transparent, creative) creates a magnetic effect. People want to be part of something real. They want to believe in where they work. That’s why everything from your careers page to your social media presence contributes to how your company is perceived as an employer. The tone of your job descriptions, the transparency in your messaging, and even the visual design of your website tell a story. Are you using that opportunity to stand out? A flat, corporate tone can deter great candidates. On the other hand, a voice that feels personal and authentic can signal your culture is different and you value people, not just productivity. Don’t forget about the power of visual identity and messaging. Both can signal innovation, openness, and trustworthiness before a candidate even clicks “apply.” So what is top talent in the cannabis space really looking for? More and more, people are drawn to companies not because “weed is cool” but because they want to work in a dynamic, emerging space full of novel challenges. These are self-motivated, growth-oriented individuals who aspire to solve problems in an industry that’s still taking shape. One of the strongest signals of a healthy employer brand is internal mobility. If employees see a real path to grow, whether that means learning new skills, stepping into leadership, or even switching departments, they’re far more likely to stay and engage. Empty promises of growth often backfire. If you want people to believe in the future of your company, make sure you’re creating a future they can be part of. But challenge alone won’t keep them. If you want to attract and retain top-tier talent, you need to provide security as well as advancement opportunities. That starts with offering real benefits. I’m talking about healthcare, paid leave, and other perks. These investments may stretch your budget, especially early on, but they demonstrate you care about the people helping your business grow. This brings me to my last point: the pizza party purpose. There was a time I thought team-building exercises were corny. And sure, a pizza party won’t fix a toxic workplace. But shared meals, casual hangs, and inside jokes over Slack channels? Honestly, these moments matter more than you’d think. They build trust. They create space for people to exhale. And sometimes, as a business owner, watching your team laugh over slices is the moment you realize you’re doing something right. [image: Dixie for mg Magazine] Photo: Dixie The goal isn’t to check off boxes on a “culture to-do list.” The goal is to create real, human moments. Sometimes, yes, a slice of pizza helps. In cannabis, employer branding isn’t just a recruitment tool. It’s a survival strategy. It’s what sets apart the companies that last from the ones that burn out. Because in the end, people don’t want just a job. They want to believe in where they work. If you get that part right — if you build a place that’s real, supportive, and driven by something deeper — you won’t just attract talent. You’ll also keep the top performers you hire. ------------------------------ Employer Branding: Key Questions 1. Why is employer branding important in cannabis? Employer branding helps cannabis companies attract and retain top talent, reducing costly turnover. 2. How can cannabis companies build a strong culture? Foster authenticity, empathy, and trust through communication, benefits, and real growth opportunities. 3. What do cannabis employees want most? Beyond perks, they want authentic culture, internal mobility, and real benefits like healthcare and paid leave. 4. How does culture affect business growth? Strong culture improves retention, productivity, and client relationships, driving long-term sustainable growth. ------------------------------ [image: Will Read co-founder CannaPlanners] As founder and CEO of CannaPlanners, Will Read brings a no-nonsense approach to disrupting the industry. His background is as dynamic as his leadership style, spanning music, tech, and entrepreneurship. After sharpening his business-development skills at Apple, he launched CannaPlanners in 2016 to normalize cannabis through bold design and next-level digital marketing. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

The Cato Institute filed an amicus brief urging the U.S. Supreme Court to hear *Canna Provisions v. Bondi*, arguing that federal marijuana prohibition under the Controlled Substances Act (CSA) is unconstitutional because it exceeds the Commerce Clause by regulating purely intrastate cannabis commerce, thereby undermining state sovereignty and federalism. The case, supported by Massachusetts-based cannabis companies, seeks relief from federal oversight and potentially revisiting the Supreme Court's precedent in *Gonzales v. Raich*. < Back Libertarian Think Tank Urges Supreme Court To Hear Marijuana Case And Restore ‘Foundational’ Constitutional Principle Nov 26, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A leading libertarian think tank is imploring the U.S. Supreme Court to take up a case challenging the constitutionality of federal marijuana prohibition, arguing that the imposition of that policy on states that have enacted laws to regulate cannabis undermines a “foundational feature of our constitutional structure.” The Cato Institute filed an amicus brief with the court on Tuesday supporting the Massachusetts-based marijuana companies that are seeking to resolve the issue and get the court to reach a ruling that protects intrastate cannabis activity from federal intervention. The Controlled Substances Act (CSA), which currently lists marijuana as a Schedule I drug, “exemplifies how the federal government has all too often displaced the states as this country’s primary policymakers, aided in that effort by this Court’s modern Commerce Clause precedents,” the institute said. “Before 1970, states regulated and then criminalized marijuana use as an exercise of their police power,” it said. “But that year, Congress enacted the CSA to ban all marijuana commerce—interstate and intrastate alike.” The amicus brief was submitted to the court on the same day that justices scheduled a closed-door meeting for next month to discuss the case, *Canna Provisions v. Bondi.* “The time has come to correct course and restore the Constitution’s first principle of limited national power,” the Cato Institute said. “This case presents an ideal vehicle for that task. By extending federal criminal law to purely intrastate, state-licensed marijuana activity, the decision below collapses the distinction between national and state authority and erases structural limits that preserve federalism.” “In criminalizing the cultivation and possession of marijuana that never crosses a state border, the CSA regulates not commerce but agriculture, manufacturing, and consumption—matters reserved to the states,” it continues. “The commerce that the CSA regulates here isn’t interstate. In Massachusetts’s marijuana program, every gram of marijuana grown, processed, transported, and sold within the Commonwealth is tracked from seed to sale under comprehensive state law.” “This case squarely presents whether Congress may wield a near-boundless commerce power to criminalize activity that is lawful under state law and confined within a state’s borders. Allowing Congress to regulate purely local conduct under a theory of aggregated economic effects erases the distinction between national and state authority on which our federal system depends. It converts the Commerce Clause into a general police power, one the Framers deliberately withheld from the national government. Such an intrusion offends the Constitution’s structural guarantee of liberty and allows an unfettered Congress to regulate nearly all aspects of our lives.” The powerhouse law firm Boies Schiller Flexner LLP last month submitted their petition for writ of certiorari from the court on behalf of their clients, and the Justice Department earlier this month declined the opportunity to file a brief for or against the case’s consideration by the justices. A lead attorney representing the petitioners recently told Marijuana Moment that he’s “hopeful”—albeit somewhat “nervous”—about the prospect of justices ultimately taking up the matter and deciding to address the key legal question about the constitutionality of federal cannabis prohibition. “Time is of the essence,” Josh Schiller said, noting the dramatic shift in public opinion and state laws governing cannabis. “We think that this is the right time for this case because of the need—the industry needs to get relief from federal oversight at the moment.” Before the conference was scheduled, the Koch-founded Americans for Prosperity Foundation also submitted an amicus brief encouraging justices to take the case. A U.S. appeals court rejected the arguments of the state-legal cannabis companies the firm is representing in May. It was one the latest blows to the high-profile lawsuit following a lower court’s dismissal of the claims. But it’s widely understood that the plaintiffs’ legal team has long intended the matter to end up before the nine high court justices. Four justices must vote to accept the petition for cert in order for the court to take up the case. While it is not clear if SCOTUS will ultimately take the case, one sign that at least some on court might be interested in the appeal is a 2021 statement from Justice Clarence Thomas, issued as the court denied review of a separate dispute involving a Colorado medical marijuana dispensary. Thomas’s comments at the time seemed to suggest it’d be appropriate revisit the precedent-setting case, *Gonzales v. Raich*, where the Supreme Court narrowly determined that the federal government could enforce prohibition against cannabis cultivation that took place wholly within California based on Congress’s authority to regulate interstate commerce. The initial complaint in the current case, filed in U.S. District Court for the District of Massachusetts, argued that government’s ongoing prohibition on marijuana under the CSA was unconstitutional because Congress in recent decades had “dropped any assumption that federal control of state-regulated marijuana is necessary.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* At oral arguments on appeal late last year, David Boies told judges that under the Constitution, Congress can only regulate commercial activity within a state—in this case, around marijuana—if the failure to regulate that in-state activity “would substantially interfere [with] or undermine legitimate congressional regulation of *inter*state commerce.” Boies, chairman of the firm, has a long list of prior clients that includes the Justice Department, former Vice President Al Gore and the plaintiffs in a case that led to the invalidation of California’s ban on same-sex marriage, among others. Judges, however, said they were “unpersuaded,” ruling in an opinion that “the CSA remains fully intact as to the regulation of the commercial activity involving marijuana for non-medical purposes, which is the activity in which the appellants, by their own account, are engaged.” The district court, meanwhile, said in the case that while there are “persuasive reasons for a reexamination” of the current scheduling of cannabis, its hands were effectively tied by past U.S. Supreme Court precedent in *Raich*. This comes in the background of a pending marijuana rescheduling decision from the Trump administration. President Donald Trump said in late August that he’d make a determination about moving cannabis to Schedule III of the CSA within weeks, but he’s yet to act. Meanwhile, last month the Supreme Court agreed to hear a separate case on the constitutionality of a federal law prohibiting people who use marijuana or other drugs from buying or possessing firearms. The Trump administration has argued that the policy “targets a category of persons who pose a clear danger of misusing firearm” and should be upheld. *Photo courtesy of Philip Steffan.* The post Libertarian Think Tank Urges Supreme Court To Hear Marijuana Case And Restore ‘Foundational’ Constitutional Principle appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

This article suggests five cannabis-infused recipes to enjoy before summer officially ends: Cannabis-Infused Chocolate-Covered Banana Slices for picnics, CBD and THC-Infused Energy Bites for active outings, Pot Popsicles for beach days, Almond Bliss Bars for potlucks, and Cannabis-Infused Honey for those stuck working. < Back End Summer Right With an Infused Dessert Sep 15, 2025 Katie Way Cannabis Now Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Sad but inevitably true: summer is officially drawing to a close. Away go the swimsuits and flip flops and out come the hoodies and flannel pajama pants. Whether you’re fielding summer blowout picnic invitations right and left, wondering what to bring to your friend’s beach house as a thank you gift or just looking for something to do with your time off, we suggest trying out one of Cannabis Now’s classic infused recipes for a surefire THC-fueled good time. Check out our picks below. [image: Labor Day Edibles]PHOTO Pixist If You’re Sprawling Out in a Park Cannabis-Infused Chocolate-Covered Banana Slices If you’re looking for a sweet, low octane treat that will meld perfectly with the rest of your friends’ picnic offerings, search no further. All you need for this recipe is chocolate chips, bananas, infused coconut oil and the teensy bit of foresight it’ll take to prepare these guys the night before you head out. Slip ‘em into a cooler alongside the spiked seltzer and let the compliments roll in. [image: Edibles Recipe: CBD and THC-Infused Energy Bites]PHOTO Bruce Wolf If You’re Looking to Get Active CBD and THC-Infused Energy Bites Take advantage of the waning warm weather by going for a nice hike or bike ride and bring these THC-infused granola bites along for the journey. They’re light, they’re relatively healthy and whether you’re an expert climber or a casual stroller, they’re sure to take your outdoor adventure to new heights that have nothing to do with altitude. [image: Labor Day Desserts Cannabis]PHOTO Bob Grg If You’re Soaking Up the Sun Seaside Pot Popsicles Life’s a beach, or at least life is a little bit better when you’re relaxing on one! The only thing you’ll have to worry about when you bring these little popsicle cubes on your next oceanic outing is how to keep them frosty enough that they don’t melt into a fruity, infused puddle while you’re burying your nose in the latest Sally Rooney book or splashing around in the waves. PHOTO Bruce Wolf If You’re Putting the Pot in Potluck Almond Bliss Bars If you don’t want to phone in a potluck dish, but you’re already looking to go the extra mile by providing a little more “fun” to the function, try these almond bliss bars. They’re the perfect cap to an eclectic meal and they’re more involved than rolling up a few joints and tossing them in your backpack — but barely. If your friends aren’t clamoring for the recipe on the basis of taste alone, they definitely will be once you let them know how easy these bars are to bake. PHOTO Bruce Wolf If You’re Actually Stuck Working Cannabis-Infused Honey If you are one of many unfortunate Americans whose boss isn’t letting you off the hook to celebrate the way your labor creates their capital, why not be a little bad and take a mental vacation? Sure, you might be physically behind the cash register or computer, grinding per usual, but with a few tablespoons of this infused honey in your morning cup of tea, the ineffable thing that makes you can kick it on a higher plane. How’s that for time off! *TELL US*, what are your Labor Day weekend plans? The post End Summer Right With an Infused Dessert appeared first on Cannabis Now. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

The summary covers several cannabis and psychedelics policy updates, including Sen. Rand Paul's threat to block a government shutdown bill over a provision that would recriminalize hemp products with THC, Idaho activists launching a medical cannabis legalization initiative for 2026, a poll showing Canadians believe the cannabis industry is an important economic contributor, and Arizona approving a clinical trial for whole mushroom psilocybin to treat PTSD in veterans and first responders. It also mentions a study on marijuana aroma and terpenes, state-level policy news, international developments like Lebanon legalizing medical cannabis cultivation, and business/culture news. < Back Hemp dispute threatens bill to end federal shutdown (Newsletter: October 30, 2025) Oct 30, 2025 Tom Angell Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link *ID medical marijuana initiative; Poll: Canadians say cannabis industry “important” to economy; AZ psilocybin trials; Cannabis smells study* Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: *Your support makes Marijuana Moment possible…* *Before you dig into today’s cannabis news,* I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment */ TOP THINGS TO KNOW* Sen. Rand Paul (R-KY) said he’s willing to block legislation to end the government shutdown if it contains provisions to recriminalize hemp products with a quantifiable amount of THC, as some lawmakers are pushing for. Idaho medical cannabis activists launched a signature gathering drive for a legalization initiative that they hope to qualify for the state’s 2026 ballot. A new poll of Canadians shows that six out of ten believe the cannabis industry is an “important contributor” to the nation’s economy and that marijuana use rates are now virtually identical to those for nicotine. Arizona officials have approved and funded a first-in-the-nation clinical trial using whole mushroom psilocybin to treat PTSD in first responders and military veterans—with authorization from the U.S. Food and Drug Administration. Researchers “generated and evaluated a descriptive aroma lexicon” for marijuana flower—finding that, contrary to popular belief, terpenes “poorly predicted sensory character.” - “This is crucial given the overreliance on terpene content in current Cannabis industry marketing and labeling practices.” */ FEDERAL* Former Trump administration Department of Justice spokesperson Sarah Isgur said she “did not like” the Obama administration’s move to reduce marijuana prosecutions. */ STATES* Connecticut’s attorney general sent a press release about a letter he co-led calling on Congress to recriminalize intoxicating hemp products. California’s treasurer said the state’s marijuana program is a “failure.” The Michigan Senate Education Committee held a hearing on a bill to require state officials to provide guidance on the dangers of marijuana products, tobacco and vaping to the parents of students on an annual basis. New Hampshire representatives discussed the prospects of marijuana legalization legislation. A Pennsylvania senator tweeted, “Like it or not, cannabis is here. It’s time to regulate the wild wild west.” New York regulators are facing a potential lawsuit over a marijuana product recall. A Colorado judge is considering a request to block regulators from enforcing a bulletin claiming a cannabis company is operating without a license. The Massachusetts Cannabis Control Commission rejected a motion to reaffirm votes they previously took when the now-reinstated chair was suspended. Maryland regulators awarded a grant to support cannabis job training expansion. Minnesota regulators sent a reminder about Friday’s deadline to apply for a lower-potency hemp edible license. Rhode Island regulators will host an event about cannabis business banking access on Monday. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* */ INTERNATIONAL* Lebanon legalized medical cannabis cultivation. Colombian officials approved the use of medical cannabis flower. New South Wales, Australia’s government said it supports “in principle” a recommendation to provide a legal defense to DUI charges for medical cannabis patients. */ SCIENCE & HEALTH* A study highlighted “the potential of C. sativa stem by-products as sustainable sources of bioactive compounds with anti-inflammatory properties, promoting their revaluation within circular economy models.” A study found “a significant, though inconsistent, negative association between legal cannabis prices and current cannabis use among adolescents.” */ ADVOCACY, OPINION & ANALYSIS* A poll of Texas voters found that 39 percent have heard “some” about Gov. Greg Abbott’s (R) regulations for hemp-derived cannabis products, 24 percent have heard “a lot,” 23 percent have heard “not very much” and 15 percent have heard “nothing at all.” An Oklahoma Republican Party district vice chairman authored an op-ed urging people not to sign a petition to put a marijuana legalization initiative on the ballot. */ BUSINESS* Vireo Growth Inc. and Verano Holdings Corp. reached a comprehensive settlement dismissing all outstanding litigation matters between the companies. Verano Holdings Corp. reported quarterly net revenue of $202.8 million and a net loss of $43.8 million. MariMed Inc. is exiting the Missouri market. Curaleaf is seeking an expedited hearing in its lawsuit challenging New Jersey cannabis industry labor rules. */ CULTURE* Basketball player Brandon Williams was arrested for possession of marijuana at an airport. Mike Tyson visited the Pennsylvania State Capitol to lobby for marijuana legalization. *Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.* Get our daily newsletter. Email address: Leave this field empty if you're human: The post Hemp dispute threatens bill to end federal shutdown (Newsletter: October 30, 2025) appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

A federal appeals court questioned a DEA lawyer over the agency's approximately six-year delay in ruling on a religious exemption petition from the Iowaska Church in Iowa, which seeks to use the psychedelic ayahuasca in its practice. The DEA attorney defended the protracted review, citing the need for a thorough investigation due to the substance being "extremely dangerous" and the need to verify the source of the imported ayahuasca. Judges expressed skepticism, suggesting the process should take months, not years. The church filed its petition in 2019 and also sought tax-exempt status. Similar delays have been reported by a cannabis company seeking to become a bulk manufacturer of research-grade marijuana, though a different Washington State church recently had its ayahuasca exemption approved by the DEA without legal challenges. < Back Federal Judge Calls Out DEA Over Delay On Psychedelic Church’s Petition To Use Ayahuasca In Religious Ceremonies Nov 19, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A lawyer for the Drug Enforcement Administration (DEA) faced a grilling by a federal appeals court over delays in a request for a religious group to use the psychedelic ayahuasca in their practice—a complaint similar to one that marijuana reform advocates have vented over decades amid repeated efforts to end federal cannabis prohibition. DEA has been largely sitting on a religious exemption petition from the Iowaska Church in Iowa for about six years, leading to a lawsuit that was heard by the U.S. Court of Appeals for the D.C. Circuit on Friday. An attorney representing DEA told judges that the agency “has a compelling interest in conducting a full and thorough investigation about whether an exception can be made to the Control Substances Act (CSA) based on referral or any other statute,” and that warrants the protracted review process. He added that prior Supreme Court precedent has demonstrated that ayahuasca is “an extremely dangerous substance” that had led to deaths in religious ceremonies, so “what we’re asking…is allow the agency to continue and make a thorough investigation before it makes a ruling.” There was skepticism among judges on the appeals court panel, with one stating that it should be “maybe a months-long process” to review exemption petitions and issue a ruling, “not a years-long process.” “This is not breaking massive new ground to work out these details,” he said during the oral argument, which Law360 first reported. The DEA attorney told the court that it’s “very complicated,” and this case is “very different” from other religious exemption cases that deal with the CSA. That’s partly because the agency must ensure that ayahuasca that’s imported by the church is appropriately sourced. Iowaska Church did provide information about the source of their ceremonially used psychedelic, identifying a Peru-based cultivator. But DEA said it needs extra time to “investigate this person” and “see what their track record is and make sure they’re not just diverting it to other users.” In the original lawsuit over the legal status of the Iowaska Church and its request to incorporate ayahuasca into its own ceremonies, the Justice Department last year downplayed the significance a deal hammered out between the federal government and a separate, Arizona-based church that also uses the psychedelic brew as part of its practice. The church first sent its petition to DEA asking for an exemption around ayahuasca use in 2019. The church found an unusual ally in anti-drug Sen. Chuck Grassley (R-IA), who court filings described as instrumental in expediting the regulatory appeals process back in 2021. A Grassley spokesperson told Marijuana Moment at the time that the senator’s help shouldn’t necessarily be viewed as an endorsement of the church’s point of view on psychedelics, however. Regarding the agency’s initial delay in processing the religious exemption request, the DEA attorney conceded on Friday that it’s “concerning.” However, he said DEA “has been acting as fast as it could, consistent with other responsibilities and with…very complex issues about how to make sure that this material is safely used and is not diverted for other uses.” One of the appeals court judges said that, from his perspective, “this is less about the complexity and sensitivity of the decision—which may very well be true—but I don’t know how I can look at this record and think that anyone at DEA was doing anything about this case for the past 15 months.” Another judge stated that there’s “been a lot of extensive delays here, and some are attributable to the government and some to the church.” “So tell me if there’s anything wrong with this framing, which at the beginning of the process, there was a long concerning three-year delay by DEA. Then there was a long concerning 16-month delay by the church, which would have entitled you to deem the application abandoned,” he said. In addition to the church’s request to obtain and use the psychedelic in its practices, it has also sought tax-exempt status as a religious institution under the Religious Freedom Restoration Act (RFRA). The church says it has not incorporated the hallucinogen in its services since 2019 after the Internal Revenue Service (IRS) responded to an information request stating that the activity was considered illegal. It also has never conducted ceremonies at the church’s Iowa address and the sacramental ingredients have never been stored there, Bill Boatwright, an attorney representing Iowaska in the case, told Marijuana Moment in 2022. Following the appeals court hearing on Iowaska Church’s case, the cannabis company MMJ BioPharma Cultivation said in a press release that it’s similarly faced years-long delays with DEA processing its 2018 petition to become a bulk manufacturer of research-grade marijuana. On the other side of the spectrum, a Washington State church said in May that DEA approved its application for an exception under federal drug laws to use ayahuasca in religious ceremonies—and, for the first time, the agency granted the unique exemption without legal challenges. *Photo courtesy of Apollo.* The post Federal Judge Calls Out DEA Over Delay On Psychedelic Church’s Petition To Use Ayahuasca In Religious Ceremonies appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

A Missouri campaign, Missourians for a Single Market, has filed four versions of 2026 ballot initiatives to unify hemp and marijuana regulations, creating parity between the two industries. The proposals aim to revise the licensing system, amend current laws, and give lawmakers constitutional mandates to develop statutory rules, striking much of the language from the 2022 marijuana legalization law. The initiatives have differences in tax policies and regulatory authority over THC-infused beverages. The campaign plans to gather signatures for one version of the Single Market Amendment, but faces potential complications from proposed legislative changes to congressional district maps and signature requirements. Not everyone in the cannabis space supports the proposal, with some arguing it would "repeal" the voter-approved legalization law and primarily benefit the hemp market. Proponents, like Eapen Thampy, aim to end the "monopoly" and create a "free and regulated market." The initiatives include provisions such as no limits on licenses, geographic restrictions, or individual/entity licensing requirements stricter than those for alcohol or tobacco, no purchase/possession limits for marijuana or hemp, and allowing individuals to grow and sell their own cannabis directly to consumers or retailers. Other provisions include self-certification for medical marijuana patients, expungements for past cannabis convictions, and retroactive state-level tax relief for cannabis businesses. Tax proposals vary, with some imposing an 11% tax for the first 10 years, benefiting a veterans health fund, while others immediately adopt an alcohol parity taxing model. < Back Missouri Activists File Initiatives To Unify Marijuana And Hemp Regulations For 2026 Ballot Sep 9, 2025 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link A Missouri campaign has filed a series of 2026 ballot initiatives that aim to unify hemp and marijuana regulations by creating parity between the two cannabis industries with a revised licensing system and legislative mandates to amend current laws. Missourians for a Single Market submitted four versions of the proposal with the secretary of state’s office on Tuesday. While the crux of the measures are the same, there are differences with respect to policies around taxes and regulatory authority over THC-infused beverages, for example. The marijuana legalization law that voters passed in 2022 enshrined regulations in the state Constitution, limiting the legislature’s ability to make certain adjustments. The coalition behind the new initiatives is aiming to strike much of that language and instead give a constitutional mandate for lawmakers to develop statutory rules themselves. Now that the measures are filed with the secretary of state’s office, there will be a 50-day review process after which officials can certify the language and clear advocates for signature gathering. Once the campaign decides which version of the Single Market Amendment to pursue, the plan is to gather about 300,000 signatures from registered voters, beginning this fall. About 180,000 must be valid to secure ballot placement, with specific requirements for signature thresholds from the state’s congressional districts. But that process could be complicated if the legislature moves forward with a pair of proposals that are being considered during an ongoing special session. One would revise Missouri’s congressional district map in a way that advantages Republicans and the other would require initiatives to get majority support in every congressional district across the state in order to be enacted. Also, not everyone in the cannabis space is on board with the new reform proposal, with at least one Missouri marijuana industry association arguing that it would amount to a “repeal” of the voter-approve legalization law, while primarily benefitting the hemp market. “Opposition from marijuana monopoly interests has blocked the pathway for reasonable legislation to regulate hemp,” Eapen Thampy, lead petitioner for the new effort, said in a press release on Tuesday. “Meanwhile thousands of businesses and their employees face persistent political jeopardy as the marijuana industry corruptly influences the levers of government. The Single Market Amendment seeks to end the monopoly and create a free and regulated market without favoritism.” The measures say lawmakers “shall not create limits on the number of licenses issued, geographic restrictions stronger than those for the sale of alcohol or tobacco, or individual/entity licensing requirements stricter than those for retail establishments selling tobacco or alcohol.” They additionally specify that licensing fees for cannabis retail businesses could not exceed those for retail liquor sales. There also would no longer be a purchase or possession limit for marijuana or hemp. Among the initiatives’ provisions is one particularly unique policy that would make it so people could not only grow their own cannabis at their private residence, but also sell the product directly to other adult consumers or to retailers through a regulated pathway that involves testing. “We want to expand and protect the ability of the individual adults to grow their own cannabis and process it for their own use,” Thampy told Marijuana Moment last month. “Part of this is ensuring that hemp is regulated and protected, and marijuana is brought down to the free market level in terms of who can produce and sell it fairly,” he said. Other notable provisions in the initiatives include those that would allow adults to self-certify as medical marijuana patients, provide a pathway for expungements for those with convictions for possession, sale or distribution of cannabis before August 28, 2027 and mandate retroactive state-level tax relief for cannabis businesses that have been deprived of their ability to deduct federal taxes under the Internal Revenue Service code known as 280E. The four initiatives that were filed on Tuesday share the same fundamental goal, but there are unique differences. For example, two of the measures would impose an 11 percent tax on marijuana and hemp for the first 10 years of implementation. Those tax dollars would be collected by the Department of Revenue to cover administrative costs and then the remainder would go to a veterans health fund. After that, cannabis would be taxed “using a per-dose equivalency model, not exceeding taxes applied to alcohol, based on independent scientific standards and public health data, reflecting comparable psychoactive effects to alcohol.” The other two initiatives use the alcohol parity taxing model immediately after enactment. Two versions would task lawmakers with enacting regulations for hemp THC beverages that model existing rules for alcohol. *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* Andrew Mullins, executive director of the MoCannTrade, told Marijuana Moment in June that the forthcoming initiative would effectively “repeal Missouri’s twice voter-approved cannabis legalization” laws, referring to the passage of medical and adult-use reform measures. “Missouri’s licensed, regulated marijuana industry generated $241 million in state and local tax revenues last year alone and is roundly regarded as one of the most impactful in the entire country,” he said at the time. Drastically changing the state’s cannabis policy “would be a spectacular failure, especially since it’s funded by bad actors who are currently selling unregulated cannabis made overseas to Missouri children in gas stations and smoke shops,” Mullins argued. “Missourians aren’t about to take hundreds of millions away from local communities, veterans and our justice system, all in hopes that politicians will eventually replace it with something down the road. The voters of the Show-Me-State are far too smart for that bait and switch.” Meanwhile, Missouri’s hemp market has been facing increased pressure from the state as officials attempt to crack down on businesses selling intoxicating cannabis products such as THCA outside of the marijuana program. The state attorney general sent over a dozen cease-and-desist orders to such businesses in June, threatening potential legal action for non-compliant businesses. Lawmakers have contemplated multiple approaches, with different details on what kinds of products would be allowed and what limits would be set on THC levels in the products. In February, legislation allowing low-dose intoxicating hemp beverages to continue to be sold in grocery and liquor stores was reported favorably by committees in both the House and Senate but was not enacted into law. *Read the text of the Missouri marijuana ballot initiatives below: * The post Missouri Activists File Initiatives To Unify Marijuana And Hemp Regulations For 2026 Ballot appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

A local dispensary achieved 30% delivery sales in two months and plans to become Brooklyn's largest cannabis delivery service by summer 2026. < Back Greenpoint Dispensary Green Apple Eyes Brooklyn Delivery Dominance After Explosive Growth Sep 17, 2025 Cannabis Business Times Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The local dispensary achieved 30% delivery sales in just two months and is aiming to become Brooklyn’s largest cannabis delivery service by summer 2026. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5

Trump Signs Bill Continuing To Block D.C. From Legalizing Recreational Marijuana Sales As Advocates Await Rescheduling Action < Back Trump Signs Bill Continuing To Block D.C. From Legalizing Recreational Marijuana Feb 4, 2026 Kyle Jaeger Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link As advocates and stakeholders await action on a federal marijuana rescheduling proposal, President Donald Trump has signed large-scale spending legislation that continues a longstanding policy blocking Washington, D.C. from legalizing recreational cannabis sales. Despite District voters approving adult-use legalization for personal possession and cultivation at the ballot more than a decade ago, local officials have been consistently prevented from allowing commercial sales due to an appropriations rider included in a funding bill covering Financial Services and General Government (FSGG). That rider, championed by Rep. Andy Harris (R-MD), was maintained in the latest version approved by Congress and signed by the president on Wednesay as part of a large-scale funding package. *Here’s the text of the D.C. sales rider:* “SEC. 809. (a) None of the Federal funds contained in this Act may be used to enact or carry out any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative. (b) No funds available for obligation or expenditure by the District of Columbia government under any authority may be used to enact any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative for recreational purposes.” For what it’s worth, while the rider was left intact in this latest FSGG bill, its main sponsor, Harris, may be at risk of being unseated in November due to redistricting in his state. The Maryland House of Delegates on Monday approved a congressional redistricting proposal that would leave anti-cannabis Harris especially vulnerable in the next election, according to analysts, giving Democrats an advantage in the state’s first congressional district for the first time since the last map was drawn in 2011. It remains to be seen whether the Senate will follow the House’s lead to pass the legislation, however. While the renewal of the rider represents a setback for advocates, congressional analysts say that, if federal officials follow through with moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), that could free up D.C. to create a system of regulated sales. In a report published in 2024, the Congressional Research Service (CRS) said that while federal cannabis prohibition would still be the law of the land, it “would permit the District government, as a matter of local law, to authorize the commercial sale of recreational marijuana, establish market regulations, and levy marijuana taxes, among other policy options.” There is a complication, however, because the congressional provision that’s been annually renewed since 2014 also stipulates that the District of Columbia can’t use funds to legalize or reduce penalties for “any tetrahydrocannabinols derivative.” But that term isn’t clearly defined in the rider or anywhere else in federal law. “The continued prohibition on legalization of tetrahydrocannabinols derivatives by the District could lead to interpretive questions about whether a particular substance is legally marijuana, hemp, a tetrahydrocannabinols derivative, or something else,” the 2024 CRS report says. “Certain synthetic tetrahydrocannabinols remain illegal for recreational use under D.C. law, but it is not clear whether these synthetic substances would constitute derivatives,” it says. “In addition, although federal law defines marijuana and hemp to be exclusive of each other, a substance could conceivably be both a tetrahydrocannabinols derivative and marijuana or hemp as a matter of law.” *— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.* *Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. —* One of the nation’s top cannabis advocacy groups, NORML, also posted an analysis in 2024 arguing that rescheduling could “open a door” for D.C. to finally legalize adult-use marijuana sales. The group suggested that the term tetrahydrocannabinols derivative “is unlikely to be interpreted by a court as inclusive of marijuana generally.” In 2021, the Government Accountability Office (GAO) separately responded to a congressional inquiry and affirmed that, even with the D.C. marijuana sales ban in place, local lawmakers there can still take steps to prepare for the potential creational of a regulated recreational marijuana market. Medical cannabis sales are already legal in D.C. Last March, the White House claimed that marijuana reform in Washington, D.C. is an example of a “failed” policy that “opened the door to disorder.” The Trump administration last year asked a federal court to dismiss a lawsuit from a D.C. hemp business challenging the federal government over the congressional budget restriction preventing cannabis sales. About three months after Capitol Hemp filed the suit in U.S. District Court for the District of Columbia, the Justice Department in September submitted a motion requesting dismissal of the case, largely on procedural grounds. The court agreed the next month. The post Trump Signs Bill Continuing To Block D.C. From Legalizing Recreational Marijuana Sales As Advocates Await Rescheduling Action appeared first on Marijuana Moment. < Previous Next > Recent Reviews Blue Lobster - The Flowery (Florida Medical) Snagging Blue Lobster from The Flowery in Florida feels like reeling in a rare catch—those award-winning Maine Trees buds live up to the hype of being as elusive as the 1-in-2-million blue lobster they're named for. This hybrid (Apples & Bananas x Eye Candy) swept the 2023 East Coast Zalympix with "Gassiest," "Best Terps," and runner-up "Best Overall," proving Maine Trees' cultivation prowess. The Flowery's locations across Florida make it accessible, and the jar's contents d Air Mail by Fade Co. - Story Dispensary (Silver Spring, Maryland) Receiving a package of Air Mail from Fade Co. at Story Dispensary in Silver Spring, Maryland, felt like getting a first-class dispatch from the clouds—sealed with a stamp of sophistication and ready to take my senses on a transcontinental journey. The dispensary's seamless service, with staff offering winged wisdom on strains, paired perfectly with Silver Spring's dynamic pulse of urban elegance and green spaces. Unsealing the jar at home, I was greeted by robust, resin-laden Cookies Gary Payton & Velvetz Dual Chamber Terp Vape - Takoma Wellness Center The Cookies Dual Chamber 3-in-1 cannabis terp vape is an innovative and intriguing addition to the vaping scene at Takoma Wellness Center... 1 2 3 4 5